Brenda Waning

Summary

Affiliation: Boston University
Country: USA

Publications

  1. ncbi Balancing medicine prices and business sustainability: analyses of pharmacy costs, revenues and profit shed light on retail medicine mark-ups in rural Kyrgyzstan
    Brenda Waning
    Department of Family Medicine, Boston University School of Medicine, One Boston Medical Center Place, Dowling 5 South, Boston, MA 02118, USA
    BMC Health Serv Res 10:205. 2010
  2. ncbi Towards equitable access to medicines for the rural poor: analyses of insurance claims reveal rural pharmacy initiative triggers price competition in Kyrgyzstan
    Brenda Waning
    Boston University School of Medicine, Department of Family Medicine One Boston Medical Center Place, Dowling 5 South, Boston, MA 02118, USA
    Int J Equity Health 8:43. 2009
  3. ncbi Global strategies to reduce the price of antiretroviral medicines: evidence from transactional databases
    Brenda Waning
    Boston University School of Medicine, Boston, MA 02118, United States of America
    Bull World Health Organ 87:520-8. 2009
  4. ncbi Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets
    Brenda Waning
    Department of Family Medicine, Boston University School of Medicine, One Boston Medical Center Place, Dowling 5 South, Boston, MA 02118, USA
    Global Health 6:9. 2010
  5. ncbi A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries
    Brenda Waning
    Department of Family Medicine, Boston University School of Medicine, Boston, MA, USA
    J Int AIDS Soc 13:35. 2010
  6. ncbi The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children
    Brenda Waning
    Department of Family Medicine, Boston University School of Medicine, One Boston Medical Center Place, Dowling 5 South, Boston, MA 02118, USA
    BMC Pediatr 10:74. 2010
  7. ncbi Assessing the population health impact of market interventions to improve access to antiretroviral treatment
    Till Barnighausen
    Department of Global Health and Population, Harvard School of Public Health, Boston, MA 02115, USA
    Health Policy Plan 27:467-76. 2012
  8. ncbi 25 years of the WHO essential medicines lists: progress and challenges
    Richard Laing
    Boston University School of Public Health, Boston, MA 02118, USA
    Lancet 361:1723-9. 2003

Detail Information

Publications8

  1. ncbi Balancing medicine prices and business sustainability: analyses of pharmacy costs, revenues and profit shed light on retail medicine mark-ups in rural Kyrgyzstan
    Brenda Waning
    Department of Family Medicine, Boston University School of Medicine, One Boston Medical Center Place, Dowling 5 South, Boston, MA 02118, USA
    BMC Health Serv Res 10:205. 2010
    ..Health services research is needed to develop sustainable and "reasonable" medicine price goals and strategic initiatives to reach them...
  2. ncbi Towards equitable access to medicines for the rural poor: analyses of insurance claims reveal rural pharmacy initiative triggers price competition in Kyrgyzstan
    Brenda Waning
    Boston University School of Medicine, Department of Family Medicine One Boston Medical Center Place, Dowling 5 South, Boston, MA 02118, USA
    Int J Equity Health 8:43. 2009
    ..The objective of this study was to determine if the establishment of the RPI resulted in the unforeseen benefit of triggering medicine price competition in pre-existing (non-RPI) private pharmacies located in the region...
  3. ncbi Global strategies to reduce the price of antiretroviral medicines: evidence from transactional databases
    Brenda Waning
    Boston University School of Medicine, Boston, MA 02118, United States of America
    Bull World Health Organ 87:520-8. 2009
    ....
  4. ncbi Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets
    Brenda Waning
    Department of Family Medicine, Boston University School of Medicine, One Boston Medical Center Place, Dowling 5 South, Boston, MA 02118, USA
    Global Health 6:9. 2010
    ..Global initiatives aim to promote efficient global ARV markets, yet little is known about market dynamics and the impact of global policy interventions...
  5. ncbi A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries
    Brenda Waning
    Department of Family Medicine, Boston University School of Medicine, Boston, MA, USA
    J Int AIDS Soc 13:35. 2010
    ..Reliable quantitative estimates of the Indian role in generic global ARV supply are needed to understand potential impacts of such measures on HIV/AIDS treatment in developing countries...
  6. ncbi The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children
    Brenda Waning
    Department of Family Medicine, Boston University School of Medicine, One Boston Medical Center Place, Dowling 5 South, Boston, MA 02118, USA
    BMC Pediatr 10:74. 2010
    ..Research on uptake and dispersion of these improved products across countries and international organizations has not been conducted but is needed to inform next steps towards improving child health...
  7. ncbi Assessing the population health impact of market interventions to improve access to antiretroviral treatment
    Till Barnighausen
    Department of Global Health and Population, Harvard School of Public Health, Boston, MA 02115, USA
    Health Policy Plan 27:467-76. 2012
    ..We offer seven recommendations for ex ante and ex post assessment of population health impact of market interventions...
  8. ncbi 25 years of the WHO essential medicines lists: progress and challenges
    Richard Laing
    Boston University School of Public Health, Boston, MA 02118, USA
    Lancet 361:1723-9. 2003
    ..This approach has required an engagement by WHO on issues such as the effect of international trade agreements on access to essential medicines and research and development to ensure availability of new essential medicines...